Beichen Ding
Harbin, 150001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Enhancer-mediated DDIT4 activation by SMYD2-dependent H3K4me1 promotes pazopanib resistance in clear cell renal cell carcinoma.
Journal: Journal of translational medicine
Published: May 20, 2026
APOBEC3C Suppresses Prostate Cancer by Regulating Key Molecules Involved in Cellular Inflammation, Cell Cycle Arrest, and DNA Damage Response.
Journal: Cancers
Published: November 28, 2025
Identification of metastasis-related genes for predicting prostate cancer diagnosis, metastasis and immunotherapy drug candidates using machine learning approaches.
Journal: Biology direct
Published: May 15, 2024
Multi-omics analysis and experimental validation of the value of monocyte-associated features in prostate cancer prognosis and immunotherapy.
Journal: Frontiers in immunology
Published: May 01, 2024
Evaluating the predictive value of angiogenesis-related genes for prognosis and immunotherapy response in prostate adenocarcinoma using machine learning and experimental approaches.
Journal: Frontiers in immunology
Published: April 13, 2024
Common immunological and prognostic features of lung and bladder cancer via smoking-related genes: PRR11 gene as potential immunotherapeutic target.
Journal: Journal of cellular and molecular medicine
Published: January 17, 2024
Unveiling the role of YARS1 in bladder cancer: A prognostic biomarker and therapeutic target.
Journal: Journal of cellular and molecular medicine
Published: December 19, 2023
Loss of SETD2-mediated downregulation of intracellular and exosomal miRNA-10b determines MAPK pathway activation and multidrug resistance in renal cancer.
Journal: Molecular carcinogenesis
Published: April 30, 2023
Corrigendum: Transcription factors BARX1 and DLX4 contribute to progression of clear cell renal cell carcinoma via promoting proliferation and epithelial-mesenchymal transition.
Journal: Frontiers in molecular biosciences
Published: August 23, 2022
Erratum: Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum.
Journal: Theranostics
Published: January 06, 2022
Integrated Analysis of the Roles of RNA Binding Proteins and Their Prognostic Value in Clear Cell Renal Cell Carcinoma.
Journal: Journal of healthcare engineering
Published: February 03, 2021
Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma via Promoting Proliferation and Epithelial-Mesenchymal Transition.
Journal: Frontiers in molecular biosciences
Published: November 21, 2020
Last Updated: 09/26/2026